It is thus significant that cholesterol binding to ERRα and cholesterol-mediated increase in ERRα-PGC-1α interaction result in increased expression of ERRα itself and its metabolic target genes including IDH3A, VEGF, SOD2, GSTM1, PDK4, SPP1 in breast cancer cells. This evidence concerns the gene SOD2 and breast carcinoma.